Axon Enterprise, Inc. (NASDAQ:AXON) Short Interest Down 17.8% in March

Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 1,570,000 shares, a drop of 17.8% from the March 15th total of 1,910,000 shares. Based on an average daily volume of 833,100 shares, the short-interest ratio is presently 1.9 days. Currently, 2.2% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of recent research reports. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target on the stock. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and an average target price of $626.45.

Insider Activity at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the sale, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of AXON. Fourth Dimension Wealth LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $30,000. Bartlett & CO. Wealth Management LLC increased its stake in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after buying an additional 33 shares during the last quarter. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise during the 4th quarter worth about $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $45,000. Finally, Alpine Bank Wealth Management acquired a new stake in shares of Axon Enterprise in the first quarter valued at about $40,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 2.4 %

AXON stock traded up $13.77 during trading hours on Thursday, reaching $590.67. 469,074 shares of the stock were exchanged, compared to its average volume of 779,663. The firm's 50-day moving average is $549.49 and its 200-day moving average is $568.33. Axon Enterprise has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a market cap of $45.98 billion, a price-to-earnings ratio of 152.63, a PEG ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.